References
Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61(3):215–25; discussion 226–9.
De Prada I, Cordobes F, Azorin D, Contra T, Colmenero I, Glez-Mediero I. Pediatric giant cell glioblastoma: a case report and review of the literature. Childs Nerv Syst. 2006;22(3):285–9.
Artico M, Cervoni L, Celli P, Salvati M, Palma L. Supratentorial glioblastoma in children: a series of 27 surgically treated cases. Childs Nerv Syst. 1993;9(1):7–9.
Klein R, Molenkamp G, Sorensen N, Roggendorf W. Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period. Childs Nerv Syst. 1998;14(6):288–91.
Margetts JC, Kalyan-Raman UP. Giant-celled glioblastoma of brain. A clinico-pathological and radiological study of ten cases (including immunohistochemistry and ultrastructure). Cancer. 1989;63(3):524–31.
Deb P, Sharma MC, Chander B, Mahapatra AK, Sarkar C. Giant cell glioblastoma multiforme: report of a case with prolonged survival and transformation to gliosarcoma. Childs Nerv Syst. 2006;22(3):314–9.
Raco A, Bristot R, Salvati M, Delfini R. Malignant supratentorial astrocytomas of late childhood. Our experience with 25 cases. Childs Nerv Syst. 1997;13(6):341–4.
Mirimanoff RO, Gorlia T, Mason W, Van Den Bent MJ, Kortmann RD, Fisher B, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol. 2006;24(16):2563–9.
Campbell JW, Pollack IF, Martinez AJ, Shultz B. High-grade astrocytomas in children: radiologically complete resection is associated with an excellent long-term prognosis. Neurosurgery. 1996;38(2):258–64.
Pollack IF, Hamilton RL, Burnham J, Holmes EJ, Finkelstein SD, Sposto R, et al. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort. Neurosurgery. 2002;50(6):1238–44; discussion 1244–5.
Malhi H, Gores GJ. TRAIL resistance results in cancer progression: a TRAIL to perdition? Oncogene. 2006;25(56):7333–5.
Cimini A, Ippoliti R. Innovative therapies against human glioblastoma multiforme. ISRN Oncol. 2011;2011:787490.
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–96.
Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352(10):997–1003.
Chaichana KL, Chaichana KK, Olivi A, Weingart JD, Bennett R, Brem H, et al. Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. J Neurosurg. 2011;114(3):587–94.
Filippini G, Falcone C, Boiardi A, Broggi G, Bruzzone MG, Caldiroli D, et al. Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol. 2008;10(1):79–87.
Bauchet L, Mathieu-Daudé H, Fabbro-Peray P, Rigau V, Fabbro M, Chinot O, et al. Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. Neuro Oncol. 2010;12(7):725–35.
Sabel M, Reifenberger J, Weber RG, Reifenberger G, Schmitt HP. Long-term survival of a patient with giant cell glioblastoma. Case report. J Neurosurg. 2001;94(4):605–19.
Karremann M, Butenhoff S, Rausche U, Pietsch T, Wolff JE, Kramm CM. Pediatric giant cell glioblastoma: new insights into a rare tumor entity. Neuro Oncol. 2009;11(3):323–9.
Bucci MK, Maity A, Janss AJ, Belasco JB, Fisher MJ, Tochner ZA, et al. Near complete surgical resection predicts a favourable outcome in pediatric patients with nonbrainstem, malignant gliomas: results from a single center in the magnetic resonance imaging era. Cancer. 2004;101(4):817–24.
Kawano H, Kubota T, Sato K, Goya T, Arikawa S, Wakisaka S. Immunohistochemical study of giant cell in glioblastoma. Clin Neuropathol. 1995;14(2):118–22.
Martinez-Diaz H, Kleinschmidt-DeMasters BK, Powell SZ, Yachnis AT. Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin. Arch Pathol Lab Med. 2003;127(9):1187–91.
Peraud A, Watanabe K, Schwechheimer K, Yonekawa Y, Kleihues P, Ohgaki H. Genetic profile of the giant cell glioblastoma. Lab Invest. 1999;79(2):123–9.
Conflict of Interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zipp, L., Schwartz, K., Hewer, E. et al. Magnetic Resonance Imaging and Computed Tomography Findings in Pediatric Giant Cell Glioblastoma. Clin Neuroradiol 22, 359–363 (2012). https://doi.org/10.1007/s00062-012-0130-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00062-012-0130-9